MRVI vs BCAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

MRVI

39.7
AI Score
VS
MRVI Wins

BCAB

38.8
AI Score

Investment Advisor Scores

MRVI

40score
Recommendation
SELL

BCAB

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MRVI BCAB Winner
Net Income -16.15M -96.54M MRVI
Operating Income -17.25M -101.15M MRVI
ROE -7.9% -101.9% MRVI
ROA -2.7% -63.8% MRVI
Total Assets 603.75M 151.36M MRVI
Cash 70.09M 141.28M BCAB
Current Ratio 4.05 4.14 BCAB

Relative Price Performance (Last 90 Days)

MRVI 1M: +13.0% · 3M: +25.3% BCAB 1M: -48.7% · 3M: -55.9%

Current Technical Phase

MRVI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 40.7 · Price: $6.53

BCAB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.5%), weak momentum, RSI 20

RSI (14): 20.2 · Price: $1.74

Fundamentals Snapshot

Metric MRVI BCAB
Market Cap
Forward P/E -65.0 -1.3
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.3%
Gross Margin 0.4% -1.9%
Operating Margin -0.3% 0.0%
EPS -0.52 -25.23
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MRVI is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.